Valuation Clinuvel Pharmaceuticals Limited Deutsche Boerse AG

Stocks

Market Closed - Deutsche Boerse AG Other stock markets 09:01:24 07/08/2026 +03			5-day change	1st Jan Change
5.500 ^EUR	0.00%		0.00%	-21.43%

07-30	Clinuvel Pharmaceuticals Ltd Provides Commercial Update On Vitiligo And Reports Clinical Benchmarks For SCENESSE	CI
07-30	Clinuvel Pharmaceuticals Strengthens Supply Chain as Part of Commercial Preparations for North American Vitiligo Market	MT

Data adjusted to current consolidation scope

Fiscal Period: June	2021	2022	2023	2024	2025	2026	2027	2028
Market Cap ¹	1,517	733.7	883.5	769.8	520.3	476	-	-
Change	-	-51.63%	20.4%	-12.87%	-32.41%	-8.5%	-	-
Enterprise Value (EV) ¹	1,434	612.2	726.6	585.9	296.2	223.4	191.4	156.9
Change	-	-57.31%	18.69%	-19.37%	-49.45%	-24.59%	-14.29%	-18.06%
P/E	63.4x	36.8x	30.3x	22x	14.5x	13.3x	12.6x	9.89x
PBR	15.4x	5.84x	5.37x	3.79x	2.17x	1.73x	1.55x	1.4x
PEG	-	-2.2x	0.6x	1.2x	5.06x	-9.55x	2.22x	0.4x
Capitalization / Revenue	31.6x	11.2x	11.3x	8.73x	5.48x	4.8x	4.55x	3.68x
EV / Revenue	29.9x	9.32x	9.28x	6.64x	3.12x	2.25x	1.83x	1.21x
EV / EBITDA	55x	16.4x	19.5x	12x	6.84x	5.4x	4.32x	3.28x
EV / EBIT	56.8x	16.7x	20x	12.3x	7.03x	5.58x	4.43x	3.35x
EV / FCF	77.9x	15.5x	20.2x	18.6x	7.26x	7.05x	5.27x	2.84x
FCF Yield	1.28%	6.44%	4.94%	5.37%	13.8%	14.2%	19%	35.2%
Dividend per Share ²	0.025	0.04	0.05	0.05	0.05	0.0611	0.08	0.1114
Rate of return	0.08%	0.27%	0.28%	0.33%	0.48%	0.65%	0.85%	1.18%
EPS ²	0.484	0.403	0.591	0.698	0.718	0.708	0.7482	0.9547
Distribution rate	5.17%	9.93%	8.46%	7.16%	6.96%	8.64%	10.7%	11.7%
Net sales ¹	47.98	65.72	78.32	88.18	95.02	99.21	104.6	129.3
EBITDA ¹	26.1	37.44	37.2	48.95	43.3	41.39	44.34	47.75
EBIT ¹	25.24	36.68	36.41	47.81	42.12	40.05	43.25	46.76
Net income ¹	24.73	20.88	30.6	35.64	36.17	35.72	37.66	48.15
Net Debt ¹	-82.69	-121.5	-156.8	-183.9	-224.1	-252.7	-284.6	-319.2
Reference price ²	30.700	14.850	17.880	15.370	10.380	9.440	9.440	9.440
Nbr of stocks (in thousands)	49,410	49,410	49,410	50,083	50,124	50,428	-	-
Announcement Date	8/26/21 A	8/30/22 A	8/29/23 A	8/28/24 A	8/27/25 A	-	-	-

¹AUD in Million²AUD

Estimates

Add to a list 0 selected To use this feature you must be a member Log in Sign up	P/E (Y)	EV / Sales (Y)	EV / EBITDA (Y)	Dividend Yield (Y)	Capi.($)
REGENERON PHARMACEUTICALS, INC.	18.53x	4.23x	9.95x	0.5%	78.32B
SAMSUNG BIOLOGICS CO.,LTD.	37.89x	12.96x	24.67x	-.--%	51.1B
UCB	22.65x	4.94x	14.36x	0.65%	49.18B
CSL LIMITED	-59.98x	3.47x	10.27x	3.06%	44.71B
BIOGEN INC.	37.84x	3.44x	12.89x	-.--%	30.72B
INCYTE CORPORATION	53.8x	3.4x	26.32x	-.--%	24.44B
MODERNA, INC.	-6.9x	9.48x	-6.12x	-.--%	23.62B
INNOVENT BIOLOGICS, INC.	71.12x	6.73x	44.44x	-.--%	21.05B
SWEDISH ORPHAN BIOVITRUM AB	23.75x	5.1x	13.29x	-.--%	16.61B
Average	22.08x	5.97x	16.67x	0.47%	37.75B
Weighted average by Cap.	17.73x	5.98x	15.47x	0.61%